High expression of the detoxification enzyme and bona fide NRF2 target gene NAD(P)H:quinone oxidoreductase 1 (NQO1) is a distinct biomarker of NRF2/KEAP1 mutant NSCLC tumors. Here, NQO1 is linked to non-small cell lung carcinoma.